Clinical Features and Outcomes of Immunocompromised Children Hospitalized With Laboratory-Confirmed Influenza in the United States, 2011-2015.

Autor: Collins JP; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.; Emerging Infections Program, Atlanta VA Medical Center, Atlanta, Georgia., Campbell AP; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia., Openo K; Emerging Infections Program, Atlanta VA Medical Center, Atlanta, Georgia., Farley MM; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.; Emerging Infections Program, Atlanta VA Medical Center, Atlanta, Georgia., Cummings CN; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia., Kirley PD; California Emerging Infections Program, Oakland., Herlihy R; Colorado Department of Public Health and Environment, Denver., Yousey-Hindes K; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven., Monroe ML; Maryland Department of Health and Mental Hygiene, Baltimore., Ladisky M; Michigan Department of Health and Human Services, Lansing., Lynfield R; Minnesota Department of Health, St. Paul., Baumbach J; New Mexico Department of Health, Santa Fe., Spina N; New York State Department of Health, Albany., Bennett N; University of Rochester Medical Center, New York., Billing L; Ohio Department of Health, Columbus., Thomas A; Oregon Public Health Division, Portland., Schaffner W; Vanderbilt University School of Medicine, Nashville, Tennessee., Price A; Salt Lake Valley Health Department, Salt Lake City, Utah., Garg S; Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia., Anderson EJ; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.; Emerging Infections Program, Atlanta VA Medical Center, Atlanta, Georgia.
Jazyk: angličtina
Zdroj: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2019 Dec 27; Vol. 8 (6), pp. 539-549.
DOI: 10.1093/jpids/piy101
Abstrakt: Background: Existing data on the clinical features and outcomes of immunocompromised children with influenza are limited.
Methods: Data from the 2011-2012 through 2014-2015 influenza seasons were collected as part of the Centers for Disease Control and Prevention (CDC) Influenza Hospitalization Surveillance Network (FluSurv-NET). We compared clinical features and outcomes between immunocompromised and nonimmunocompromised children (<18 years old) hospitalized with laboratory-confirmed community-acquired influenza. Immunocompromised children were defined as those for whom ≥1 of the following applies: human immunodeficiency virus/acquired immunodeficiency syndrome, cancer, stem cell or solid organ transplantation, nonsteroidal immunosuppressive therapy, immunoglobulin deficiency, complement deficiency, asplenia, and/or another rare condition. The primary outcomes were intensive care admission, duration of hospitalization, and in-hospital death.
Results: Among 5262 hospitalized children, 242 (4.6%) were immunocompromised; receipt of nonsteroidal immunosuppressive therapy (60%), cancer (39%), and solid organ transplantation (14%) were most common. Immunocompromised children were older than the nonimmunocompromised children (median, 8.8 vs 2.8 years, respectively; P < .001), more likely to have another comorbidity (58% vs 49%, respectively; P = .007), and more likely to have received an influenza vaccination (58% vs 39%, respectively; P < .001) and early antiviral treatment (35% vs 27%, respectively; P = .013). In multivariable analyses, immunocompromised children were less likely to receive intensive care (adjusted odds ratio [95% confidence interval], 0.31 [0.20-0.49]) and had a slightly longer duration of hospitalization (adjusted hazard ratio of hospital discharge [95% confidence interval], 0.89 [0.80-0.99]). Death was uncommon in both groups.
Conclusions: Immunocompromised children hospitalized with influenza received intensive care less frequently but had a longer hospitalization duration than nonimmunocompromised children. Vaccination and early antiviral use could be improved substantially. Data are needed to determine whether immunocompromised children are more commonly admitted with milder influenza severity than are nonimmunocompromised children.
(© The Author(s) 2018. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje